37 results
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
of interest with the Company. For this purpose, a “conflict of interest” exists when a Participating Member, the parent or affiliate of a Participating Member … claims that the Company may have against the Placement Agents with respect to any conflict of interest that may arise from the fact that the views
424B4
8jok62e18 hxv0
11 Oct 22
Prospectus supplement with pricing info
8:27am
8-K
EX-10.11
dkc1ppr
11 Feb 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-3.1
90jhm8
11 Feb 19
Entry into a Material Definitive Agreement
8:39am